Known for his tireless energy in providing quality patient care and in advocating for the ID specialty, Alan D. Tice, MD, FIDSA, of Honolulu, a former member of the IDSA Board of Directors and several Society committees and task forces, died on March 30, at age 69. His diverse contributions touched many areas, from outpatient parenteral antimicrobial therapy (OPAT) to urinary tract infections, new antibiotics, HIV, viral hepatitis, and managed care, among others.
“We all were amazed at what Alan Tice accomplished and wonder when he slept,” wrote R. Brooks Gainer, MD, FIDSA, in a remembrance published in Infectious Disease News. “We shall miss his boundless energy and his wit.”
Dr. Tice, who helped organize the first IDSA clinical conference in 1990 and authored both of the IDSA OPAT guidelines, served on the Clinical Affairs Committee for several years and represented IDSA in developing the Harvard Resource-Based Relative Value Scale. He also testified before Congress and the Health Care Financing Administration on behalf of the Society and helped organize the Managed Care in Infectious Diseases Conference in 1995.
Dr. Tice chaired IDSA’s Quality Measures Task Force, was the State and Regional Societies representative to the Board of Directors, was a member of the IDSA OPAT Task Force, and served on the Quality Improvement Task Force. He also served as the Society’s delegate to the American Medical Association (AMA) House of Delegates and AMA’s Physician Consortium for Performance Network. In 1996, he received IDSA’s Clinician of the Year award. He was honored with a Society Citation in 2012 for his work in patient care and long-running commitment to the Society, including his service on the Board of Directors from 2003 to 2006.
Raised in Iowa and a graduate of Harvard College and Columbia College of Physicians and Surgeons, Dr. Tice trained in internal medicine at Roosevelt Hospital in New York and New York University before completing a fellowship in infectious diseases at Tufts University’s New England Medical Center.
Prior to his retirement, Dr. Tice was an associate professor at the John A. Burns School of Medicine at the University of Hawaii. Before assuming this position, Dr. Tice started an ID practice in Washington state. There he assembled a group of ID specialists who developed programs in outpatient parenteral antimicrobial therapy, clinical research, and infection control. He also developed an outpatient ID unit that included a travel clinic, a reference microbiology laboratory, and a tuberculosis clinic.
Dr. Tice founded the Outpatient Intravenous Infusion Therapy Association (OPIVITA) and directed the organization’s Outcomes Registry. In addition to OPAT, his areas of particular interest included outcomes measures, networking, managed care, viral hepatitis, staphylococci, and appropriate antibiotic use.
He was also a founder, then president, of the Infectious Diseases Society of Washington and started the Hepatitis Resource Network for ID specialists to develop programs to improve treatment for patients with viral hepatitis. He was editor of the OPAT Newsletter and a section editor for Infectious Diseases in Clinical Practice, ID Alert, ID News, Contagion, and other publications, and served on the editorial advisory board for Clinical Infectious Diseases.
< Previous Article | Next Article >